Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program

Engineered yeast that self-destructs after fermentation could cut energy use in product recovery.

Source: GEN - Genetic Engineering and Biotechnology News, by John Sterling. AI-generated summary by biochip.com, published . Not independently reviewed.

Key takeaways

  • Manus and UT Austin engineered yeast to self-lyse after fermentation in a BioMADE-sponsored product recovery program.
  • At 300-liter pilot scale, engineered Yarrowia lipolytica cut mechanical separation energy requirements by more than 50 percent.
  • The work has not established performance across all products or at full commercial manufacturing scale.

Manus and the University of Texas at Austin have completed a BioMADE-sponsored effort to make recovering products from industrial yeast fermentations less energy-intensive. The team engineered yeast cells to break open their own cell walls after fermentation, a strategy called programmed lysis or self-destruction. That matters because many valuable bio-based products remain trapped inside microbial cells and must be released before they can be purified and used. In pilot-scale tests reaching 300 liters, engineered Yarrowia lipolytica yeast reduced the energy needed for mechanical separation by more than 50 percent. The researchers also achieved autolysis, meaning self-lysis, in an industrially relevant Saccharomyces cerevisiae production strain. Manus worked with Hal Alper, PhD, and the Alper Lab in UT Austin's McKetta Department of Chemical Engineering to move the approach beyond a small laboratory demonstration. The work targets a costly stage of biomanufacturing called downstream processing, which covers the steps used to recover and purify a product after cells have grown. By reducing the force, equipment, and chemical extraction that conventional recovery can require, the partners aim to make a wider range of intracellular bioalternative products practical to manufacture at scale.

Teaching Yeast When to Open

Yeast fermentation works much like brewing, except the desired output may be a chemical, ingredient, or material rather than beer. The microorganisms consume feedstocks and build molecules inside their cells. When the target molecule stays within the cell, manufacturers must first breach the cell wall to reach it.

That barrier is useful while fermentation is underway because it keeps the cell intact and productive. After fermentation, however, it becomes an obstacle. The Manus and UT Austin team engineered yeast so that the cells can disrupt their own walls at the end of the process, helping release the material accumulated inside.

Why Product Recovery Drives Cost

Downstream processing is the industrial equivalent of extracting and sorting ingredients after cooking a large meal. A fermentation tank may generate the desired molecule, but the manufacturer still needs to separate it from cells, water, and other fermentation components. Those recovery steps can strongly affect whether a bio-based product can compete on price.

Christine Santos, PhD, chief technology officer at Manus, identified downstream processing as one of biomanufacturing's largest hidden costs. Conventional approaches may rely on mechanical disruption to break cells apart or on solvent-based extraction. Mechanical methods consume energy, while solvent use can add handling and safety challenges.

From Mechanical Force to Autolysis

Programmed lysis is intended to replace part of that external effort with a biological instruction built into the yeast. Instead of treating every cell like a sealed container that must be forced open from the outside, the approach asks the cell to open itself when its production job is finished. The practical goal is simpler recovery with less processing intensity.

The team tested the approach in two yeasts with major industrial relevance. Yarrowia lipolytica is widely used in industrial biotechnology because it can produce oils and other compounds. Saccharomyces cerevisiae, commonly known as baker's yeast, is a long-established production organism for fermentation-based manufacturing.

Pilot Results at 300 Liters

The project demonstrated the technology at pilot scale, with fermentations of up to 300 liters. That scale does not establish full commercial deployment, but it is a meaningful step beyond small flasks and bench experiments. It tests whether a biological design can remain useful when it is integrated into a larger fermentation operation.

In engineered Yarrowia lipolytica, the group reported a reduction of more than 50 percent in mechanical separation energy requirements. In Saccharomyces cerevisiae, the team achieved autolysis in a production strain relevant to industrial use. Together, those demonstrations moved the work from laboratory proof of concept toward integrated pilot operation.

Potential Products Inside the Cell

The strategy could apply to products that microbes make and store internally. Manus and UT Austin identified lipids, proteins, vitamins, pigments, biosurfactants, and polysaccharides as possible targets. A biosurfactant is a biological molecule that helps liquids mix or spread, while a polysaccharide is a long chain of sugar molecules used in products ranging from food ingredients to materials.

These product categories differ chemically, but they share the same basic recovery challenge when they accumulate inside a yeast cell. A more efficient way to release intracellular material could therefore be useful across multiple fermentation processes. The benefit would depend on how well self-lysis works with a particular yeast strain, product, and purification workflow.

Connecting University Research and Manufacturing

Hal Alper said the collaboration joined academic and industrial settings to translate bench-scale discoveries more rapidly toward higher technology readiness. That connection is important in biomanufacturing because a genetic change that works in a research setting must also fit the realities of larger tanks, industrial strains, and recovery equipment. The 300-liter operation gave the partners a chance to evaluate that transition.

BioMADE supported the program as part of its focus on strengthening domestic bioindustrial manufacturing. Manus said that lowering processing intensity and improving product recovery could support production based on abundant, lower-cost American feedstocks. The work is therefore about both a cell-engineering tool and the economics of turning fermentation into manufactured goods.

Why This Matters

Fermentation often receives attention for what microbes can make, but recovery determines how much of that product can be obtained with realistic energy use and cost. If the cells can release their contents on cue, manufacturers may need less mechanical disruption and may avoid some solvent-based extraction steps. That could improve the case for bioalternative products designed to replace materials or ingredients made through other industrial routes.

The reported results do not yet show how the method will perform across every intracellular product or at commercial manufacturing scale. Still, the pilot demonstration offers a concrete route for addressing a persistent bottleneck: getting valuable molecules out of microbial cells without letting separation costs overwhelm the advantages of fermentation. Future work can test how broadly programmed lysis transfers among organisms, products, and industrial process conditions.